Atlas Trials

Dual Sympathetic Blocks for Patients Experiencing Sympathetically-Mediated Symptoms From Long COVID

Clinical trial NCT05638620 · COMPLETED

Trial details

NCT number
NCT05638620
Sponsor
Jonathann Kuo, MD
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Post Acute COVID-19 SyndromeLong COVIDLong Covid19COVID-19 RecurrentPost-Acute COVID-19Post-Acute COVID-19 InfectionSARS-CoV2 InfectionPost Acute Sequelae of COVID-19DysautonomiaDysautonomia Like DisorderDysautonomia Orthostatic Hypotension SyndromePost COVID-19 Condition
Start date
2023-01-03
Primary completion
2023-06-15
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.